Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Keros Therapeutics price target lowered by $5 at BofA, here's why » 06:45
09/12/24
09/12
06:45
09/12/24
06:45
KROS

Keros Therapeutics

$54.89 /

+0.17 (+0.31%)

BofA lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a week ago
Hot Stocks
Keros Therapeutics closes screening for Phase 2 trial of cibotercept » 08:28
09/03/24
09/03
08:28
09/03/24
08:28
KROS

Keros Therapeutics

$45.29 /

+0.017 (+0.04%)

Keros Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Keros Therapeutics director sells $11.0M in common stock » 17:18
08/15/24
08/15
17:18
08/15/24
17:18
KROS

Keros Therapeutics

$45.95 /

+2.57 (+5.92%)

In a regulatory filing,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Keros Therapeutics participates in a conference call with Cantor Fitzgerald » 12:50
08/15/24
08/15
12:50
08/15/24
12:50
KROS

Keros Therapeutics

$46.05 /

+2.67 (+6.15%)

Conference call with…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Keros Therapeutics participates in a conference call with Cantor Fitzgerald » 10:39
08/15/24
08/15
10:39
08/15/24
10:39
KROS

Keros Therapeutics

$44.56 /

+1.18 (+2.72%)

Conference call with…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Keros Therapeutics reports Q2 EPS ($1.25), consensus ($1.23) » 16:06
08/07/24
08/07
16:06
08/07/24
16:06
KROS

Keros Therapeutics

$45.47 /

-3.38 (-6.92%)

"Keros continued to…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Keros Therapeutics initiated with an Outperform at Oppenheimer » 16:14
06/24/24
06/24
16:14
06/24/24
16:14
KROS

Keros Therapeutics

$46.46 /

+0.035 (+0.08%)

Oppenheimer initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Hot Stocks
Keros Therapeutics appoints CEO Jasbir Seehra as Chair of Board » 16:05
06/17/24
06/17
16:05
06/17/24
16:05
KROS

Keros Therapeutics

$44.53 /

-4.79 (-9.71%)

Keros Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Keros Therapeutics to hold a corporate update conference call » 07:50
06/17/24
06/17
07:50
06/17/24
07:50
KROS

Keros Therapeutics

$49.32 /

-0.1 (-0.20%)

Management holds a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Keros Therapeutics presents data from Phase 2 RESTORE trial of elritercept » 06:06
06/17/24
06/17
06:06
06/17/24
06:06
KROS

Keros Therapeutics

$49.32 /

-0.1 (-0.20%)

Elritercept Demonstrated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Keros Therapeutics presents clinical data from elritercept program » 06:04
06/17/24
06/17
06:04
06/17/24
06:04
KROS

Keros Therapeutics

$49.32 /

-0.1 (-0.20%)

Keros Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Keros Therapeutics to hold a corporate update conference call » 04:55
06/17/24
06/17
04:55
06/17/24
04:55
KROS

Keros Therapeutics

$49.32 /

-0.1 (-0.20%)

Management holds a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Keros Therapeutics to hold a corporate update conference call » 16:29
06/14/24
06/14
16:29
06/14/24
16:29
KROS

Keros Therapeutics

$49.32 /

-0.1 (-0.20%)

Management holds a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Keros Therapeutics price target raised by $11 at Wells Fargo, here's why » 06:47
05/09/24
05/09
06:47
05/09/24
06:47
KROS

Keros Therapeutics

$58.13 /

-0.475 (-0.81%)

Wells Fargo raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Keros Therapeutics reports Q1 EPS ($1.21), consensus ($1.35) » 08:05
05/08/24
05/08
08:05
05/08/24
08:05
KROS

Keros Therapeutics

$58.60 /

-1.67 (-2.77%)

Keros' cash and cash…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Keros Therapeutics files automatic mixed securities shelf 08:03
05/03/24
05/03
08:03
05/03/24
08:03
KROS

Keros Therapeutics

$57.13 /

-0.715 (-1.24%)

 
Conference/Events
Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call » 12:10
04/04/24
04/04
12:10
04/04/24
12:10
MRK

Merck

$129.54 /

-0.34 (-0.26%)

, GOSS

Gossamer Bio

$1.13 /

+0.02 (+1.80%)

, KROS

Keros Therapeutics

$64.95 /

+0.99 (+1.55%)

Pharmaceuticals Analysts…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Morphic appoints Cooper as Chief Medical Officer » 08:04
03/19/24
03/19
08:04
03/19/24
08:04
MORF

Morphic

$33.40 /

-1.185 (-3.43%)

, KROS

Keros Therapeutics

$63.88 /

-3.523 (-5.23%)

Morphic Therapeutic…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Keros Therapeutics announces Fast Track designation for KER-050 » 08:11
03/14/24
03/14
08:11
03/14/24
08:11
KROS

Keros Therapeutics

$67.72 /

+0.12 (+0.18%)

Keros Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Keros Therapeutics initiated with a Not Rated at Goldman Sachs » 05:39
03/13/24
03/13
05:39
03/13/24
05:39
KROS

Keros Therapeutics

$67.60 /

+1.365 (+2.06%)

Goldman Sachs analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Keros Therapeutics price target raised by $17 at Wells Fargo, here's why » 06:20
02/29/24
02/29
06:20
02/29/24
06:20
KROS

Keros Therapeutics

$68.09 /

-1.91 (-2.73%)

Wells Fargo raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Keros Therapeutics reports Q4 EPS ($1.34) , consensus ($1.37) » 16:12
02/28/24
02/28
16:12
02/28/24
16:12
KROS

Keros Therapeutics

$68.05 /

-1.95 (-2.79%)

"In 2023, Keros made…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Truist biotech analysts hold an analyst/industry conference call » 11:45
02/26/24
02/26
11:45
02/26/24
11:45
BMY

Bristol Myers

$51.17 /

-0.5 (-0.97%)

, KROS

Keros Therapeutics

$66.77 /

+3.145 (+4.94%)

, ABBV

AbbVie

$179.24 /

+1.07 (+0.60%)

, CRIS

Curis

$9.73 /

+0.32 (+3.40%)

Biotech Analysts…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Truist biotech analysts hold an analyst/industry conference call » 04:55
02/26/24
02/26
04:55
02/26/24
04:55
BMY

Bristol Myers

$51.67 /

+0.35 (+0.68%)

, KROS

Keros Therapeutics

$63.63 /

+2.65 (+4.35%)

, ABBV

AbbVie

$178.17 /

+1.37 (+0.77%)

, CRIS

Curis

$9.41 /

-0.49 (-4.95%)

Biotech Analysts…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Truist biotech analysts hold an analyst/industry conference call » 12:10
02/21/24
02/21
12:10
02/21/24
12:10
BMY

Bristol Myers

$50.02 /

+0.14 (+0.28%)

, KROS

Keros Therapeutics

$61.24 /

+0.43 (+0.71%)

, ABBV

AbbVie

$174.58 /

-1.17 (-0.67%)

, CRIS

Curis

$10.34 /

+0.145 (+1.42%)

Biotech Analysts…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Keros Therapeutics initiated with bullish view at William Blair, here's why » 07:12
02/21/24
02/21
07:12
02/21/24
07:12
KROS

Keros Therapeutics

$60.81 /

+1.29 (+2.17%)

William Blair initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Keros Therapeutics 3.5M share Spot Secondary priced at $40.00 » 00:06
01/04/24
01/04
00:06
01/04/24
00:06
KROS

Keros Therapeutics

$41.31 /

-1.73 (-4.02%)

The deal size was…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Fly Intel: After-Hours Movers » 18:40
01/03/24
01/03
18:40
01/03/24
18:40
RGP

Resources Connection

$13.69 /

-0.3 (-2.14%)

, SLP

Simulations Plus

$43.22 /

-1.485 (-3.32%)

, PROF

Profound Medical

$7.74 /

-0.25 (-3.13%)

, KROS

Keros Therapeutics

$41.31 /

-1.73 (-4.02%)

, FUBO

FuboTV

$2.91 /

-0.255 (-8.07%)

, CALM

Cal-Maine Foods

$54.82 /

-1.835 (-3.24%)

, DYN

Dyne Therapeutics

$14.75 /

+1.71 (+13.11%)

Check out this evening's…

Syndicate
Keros Therapeutics $120M Spot Secondary; price range $40.00-$41.26 » 18:00
01/03/24
01/03
18:00
01/03/24
18:00
KROS

Keros Therapeutics

$41.31 /

-1.73 (-4.02%)

Goldman Sachs, Leerink,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Keros Therapeutics announces $120M common stock offering » 16:06
01/03/24
01/03
16:06
01/03/24
16:06
KROS

Keros Therapeutics

$41.42 /

-1.62 (-3.76%)

Keros Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.